(Q43162278)

English

Prediction of epidermal growth factor receptor mutations in the plasma/pleural effusion to efficacy of gefitinib treatment in advanced non-small cell lung cancer

scientific article published on 14 February 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Prediction of epidermal growth factor receptor mutations in the plasma/pleural effusion to efficacy of gefitinib treatment in advanced non-small cell lung cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

author name string

Guo Jian

1

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Zhou Songwen

2

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Zhang Ling

3

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Deng Qinfang

4

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Zhang Jie

5

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Tang Liang

6

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Zhou Caicun

7

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

14 February 2010

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Journal of Cancer Research and Clinical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

136

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

1341-1347

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Detection of chromosome 3p alterations in serum DNA of non-small-cell lung cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155428

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155428

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

EGFR mutations in non-small-cell lung cancer: analysis of a large series of cases and development of a rapid and sensitive method for diagnostic screening with potential implications on pharmacologic treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155428

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial) [corrected].

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155428

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155428

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

EGFR Mutation status in Japanese lung cancer patients: genotyping analysis using LightCycler

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155428

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Twenty-two years of phase III trials for patients with advanced non-small-cell lung cancer: sobering results

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155428

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Continuous fluorescence monitoring of rapid cycle DNA amplification

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155428

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155428

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A rapid and sensitive approach to mutation detection using real-time polymerase chain reaction and melting curve analyses, using BRCA1 as an example

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155428

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of p53 mutations by single-strand conformation polymorphisms (SSCP) gel electrophoresis. A comparative study of radioactive and nonradioactive silver-stained SSCP analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155428

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

EGFR mutation and resistance of non-small-cell lung cancer to gefitinib

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155428

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155428

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155428

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155428

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155428

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155428

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Detection of epidermal growth factor receptor mutations in non-small cell lung cancer by real-time PCR using TaqMan-MGB probes]

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155428

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hematogenous dissemination of lung cancer cells during surgery: quantitative detection by flow cytometry and prognostic significance.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155428

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

EGFR mutation status in tumour-derived DNA from pleural effusion fluid is a practical basis for predicting the response to gefitinib

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155428

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mutations of the epidermal growth factor receptor gene predict prolonged survival after gefitinib treatment in patients with non-small-cell lung cancer with postoperative recurrence

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155428

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Global cancer statistics in the year 2000.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155428

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Irreversible inhibitors of the EGF receptor may circumvent acquired resistance to gefitinib

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155428

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Non-isotopic silver-stained SSCP is more sensitive than automated direct sequencing for the detection of PTEN mutations in a mixture of DNA extracted from normal and tumor cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155428

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of epidermal growth factor receptor mutations in serum as a predictor of the response to gefitinib in patients with non-small-cell lung cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155428

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of epidermal growth factor receptor mutation status in serum DNA as a predictor of response to gefitinib (IRESSA).

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155428

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155428

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictive and prognostic impact of epidermal growth factor receptor mutation in non-small-cell lung cancer patients treated with gefitinib

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155428

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lung cancer-related genes in the blood.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155428

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00432-010-0785-Z

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43162278&oldid=2205834563"